Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yutaka Niihara, MD, MPH
Researcher Professor of Medicine
David Geffen School of Medicine at UCLA
1124 West Carson Street C-1, Room 12
Torrance, California, United States
Dr. Niihara has been involved in patient care and research for sickle cell disease for most of his career, and is the principal inventor of the patented L-glutamine therapy for treatment of sickle cell disease in which he co-founded the bio-pharmaceutical company, Emmaus Life Sciences, Inc. It is now in phase III clinical trial involving 32 sites throughout US with FDA Drug Designation and Fast Track Designation. Additionally, his laboratory focuses on regenerative medicine using cell sheet technology. This treatment uses autologous progenitor cell sheets to repair damaged organs such as cornea epithelium and myocardium. Currently, he is the Professor of Medicine at the David Geffen School of Medicine at UCLA. His areas of research are sickle cell disease, cancer & carcinogenesis, blood & blood products & transfusions, biological markers and oncology specialized techniques in research such as red cell enzyme studies and red cell nucleotide analysis.
Related Content
-
Charles T. Quinn, MD, MSDr. Quinn is Associate Professor of clin...
-
Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic reviewBACKGROUND: Painful vaso-occlusive crisi...
-
Alan W. FlakeDr. Flake is an attending surgeon in the...
-
Howard University Hospital Center for Sickle Cell DiseaseTransitioning from pediatric to adult pr...
-
University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain researchThe University of Illinois at Chicago ha...
-
Montefiore Medical CenterAt the Division of Hematology at Montefi...
-
Newborn Screening Guide for ParentsMost babies born in the United States ar...